Profile data is unavailable for this security.
About the company
Apyx Medical, Inc., formerly Apyx Medical Corporation, is a surgical aesthetics company. Its segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment’s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment, designs, develops and manufactures electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs.
- Revenue in USD (TTM)47.90m
- Net income in USD-14.54m
- Incorporated1982
- Employees220.00
- LocationApyx Medical Corp5115 Ulmerton RoadCLEARWATER 33760United StatesUSA
- Phone+1 (727) 384-2323
- Fax+1 (631) 421-5821
- Websitehttps://apyxmedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CVRx Inc | 55.97m | -52.02m | 130.24m | 206.00 | -- | 2.70 | -- | 2.33 | -2.02 | -2.02 | 2.18 | 1.83 | 0.4684 | 0.7458 | 6.49 | 271,694.20 | -43.53 | -37.08 | -47.98 | -40.02 | 84.49 | 81.33 | -92.95 | -151.18 | 8.60 | -8.49 | 0.5072 | -- | 30.53 | 52.31 | -45.55 | -- | 66.61 | -- |
| LifeMD Inc | 252.34m | -7.71m | 133.82m | 304.00 | -- | 98.54 | 27.10 | 0.5303 | -0.1711 | -0.1711 | 5.66 | 0.0282 | 3.64 | 10.83 | 33.00 | 830,075.60 | -4.29 | -109.71 | -31.14 | -396.03 | 86.96 | 85.59 | -1.18 | -33.12 | 0.6645 | 0.3164 | 0.00 | -- | 39.27 | 76.32 | 7.23 | -- | -- | -- |
| Fonar Corp | 105.43m | 6.99m | 136.36m | 535.00 | 17.81 | 0.6949 | 9.72 | 1.29 | 1.04 | 1.04 | 15.74 | 26.69 | 0.4897 | 22.33 | 1.28 | 197,073.50 | 4.34 | 6.77 | 4.42 | 7.19 | 41.07 | 45.46 | 8.86 | 13.74 | 8.46 | -- | 0.0021 | -- | 1.43 | 4.02 | -21.26 | 0.1719 | -12.96 | -- |
| LENSAR Inc | 59.14m | -51.52m | 146.08m | 140.00 | -- | -- | -- | 2.47 | -4.39 | -4.39 | 4.99 | -1.02 | 0.8946 | 1.79 | 11.51 | 422,435.70 | -77.94 | -32.69 | -121.49 | -38.95 | 46.15 | 51.51 | -87.12 | -54.77 | 0.6671 | -- | -- | -- | 26.87 | 11.87 | -118.34 | -- | -40.48 | -- |
| Anika Therapeutics Inc | 82.20m | 13.91m | 147.24m | 288.00 | 10.84 | 1.00 | 7.28 | 1.79 | 0.9419 | -2.28 | 5.70 | 10.18 | 0.3907 | 0.486 | 3.25 | 285,430.60 | 6.61 | -1.87 | 7.39 | -2.06 | 54.29 | 60.74 | 16.92 | -4.73 | 4.47 | -- | 0.00 | -- | -0.7327 | 0.9077 | -156.70 | -- | 24.14 | -- |
| Apyx Medical Inc | 47.90m | -14.54m | 152.57m | 220.00 | -- | 24.06 | -- | 3.19 | -0.3644 | -0.3644 | 1.19 | 0.1546 | 0.8113 | 1.97 | 3.68 | 217,736.40 | -24.60 | -27.67 | -29.90 | -33.35 | 62.65 | 64.81 | -30.32 | -43.61 | 3.61 | -2.04 | 0.8507 | -- | -8.11 | 11.24 | -25.38 | -- | -11.11 | -- |
| InfuSystem Holdings Inc | 141.05m | 5.52m | 153.33m | 502.00 | 28.82 | 2.76 | 8.09 | 1.09 | 0.2616 | 0.2616 | 6.65 | 2.73 | 1.38 | 10.25 | 5.79 | 280,984.10 | 5.41 | 4.50 | 6.56 | 5.46 | 55.35 | 55.24 | 3.92 | 3.86 | 1.60 | 7.73 | 0.274 | 0.00 | 7.22 | 10.70 | 168.92 | 11.50 | -4.62 | -- |
| Cibus Inc | 3.79m | -118.90m | 156.17m | 157.00 | -- | 2.40 | -- | 41.16 | -3.26 | -3.26 | 0.0972 | 0.9588 | 0.0109 | -- | 4.23 | 24,165.61 | -36.11 | -80.24 | -39.32 | -89.98 | -- | -- | -3,322.54 | -1,268.46 | -- | -2.18 | 0.8131 | -- | 134.56 | -10.19 | 6.07 | -- | -22.92 | -- |
| Inogen Inc | 347.03m | -25.38m | 156.38m | 766.00 | -- | 0.7931 | -- | 0.4506 | -1.00 | -1.00 | 13.47 | 7.26 | 1.13 | 7.92 | 9.30 | 453,039.20 | -8.28 | -11.40 | -10.67 | -13.50 | 44.76 | 44.22 | -7.31 | -13.82 | 2.75 | -- | 0.00 | -- | 6.35 | -1.49 | 64.97 | -- | 38.15 | -- |
| Nano-X Imaging Ltd | 12.30m | -55.71m | 157.80m | 165.00 | -- | 0.9513 | -- | 12.83 | -0.8839 | -0.8839 | 0.195 | 2.40 | 0.0683 | 13.17 | 7.18 | 74,557.58 | -30.95 | -28.17 | -33.30 | -31.20 | -98.04 | -- | -452.82 | -1,072.25 | 3.93 | -- | 0.0201 | -- | 13.91 | -- | 11.95 | -- | 85.79 | -- |
| Acme United Corp | 194.96m | 10.02m | 168.37m | 633.00 | 18.17 | 1.45 | 10.36 | 0.8636 | 2.43 | 2.43 | 47.35 | 30.41 | 1.15 | 2.03 | 6.35 | 307,993.70 | 5.92 | 7.26 | 6.81 | 8.54 | 39.51 | 36.34 | 5.14 | 5.68 | 1.75 | 8.57 | 0.1962 | 18.40 | 1.56 | 6.42 | -43.67 | 12.70 | 33.59 | 4.56 |
| Citrine Global Corp | 0.00 | -1.74m | 169.70m | 18.00 | -- | -- | -- | -- | -0.0016 | -0.0016 | 0.00 | -0.0031 | 0.00 | -- | -- | 0.00 | -118.80 | -238.43 | -- | -- | -- | -- | -- | -186,483.40 | -- | -2.10 | -- | -- | -- | -- | 25.99 | -- | -- | -- |
| Accendra Health Inc | 6.71bn | -410.53m | 173.26m | 13.50k | -- | -- | -- | 0.0258 | -5.33 | -17.41 | 86.97 | -5.56 | 1.47 | 7.59 | 15.52 | 496,837.20 | -9.01 | -0.3346 | -17.40 | -0.5248 | 26.13 | 18.20 | -6.12 | -0.146 | 0.8386 | 1.67 | 1.25 | -- | 3.55 | 3.04 | -778.15 | -- | 34.30 | -- |
| Rapid Micro Biosystems Inc | 30.52m | -44.29m | 173.30m | 163.00 | -- | 3.91 | -- | 5.68 | -0.9984 | -0.9984 | 0.6884 | 1.00 | 0.3209 | 1.33 | 6.40 | 187,257.70 | -46.56 | -38.13 | -56.14 | -43.36 | 7.72 | -27.98 | -145.11 | -253.02 | 2.95 | -- | 0.3003 | -- | 24.57 | 11.18 | 10.63 | -- | -4.24 | -- |
| Lucid Diagnostics Inc | 4.40m | -65.84m | 174.13m | 72.00 | -- | -- | -- | 39.58 | -0.8968 | -0.8968 | 0.0526 | 0.1973 | 0.1161 | 12.24 | 14.94 | 61,097.22 | -140.60 | -139.37 | -301.55 | -297.39 | -58.13 | -- | -1,211.30 | -2,492.79 | 1.88 | -- | 0.4633 | -- | 79.00 | -- | -0.6817 | -- | -- | -- |
| Edap Tms SA (ADR) | 75.71m | -23.29m | 174.59m | 310.00 | -- | 6.31 | -- | 2.31 | -0.6221 | -0.6221 | 2.02 | 0.7401 | 0.9081 | 2.08 | 3.62 | 244,219.90 | -27.94 | -11.18 | -49.24 | -15.86 | 43.24 | 42.19 | -30.77 | -16.63 | 0.9729 | -- | 0.2062 | -- | 6.11 | 7.38 | 10.20 | -- | 55.92 | -- |
Data as of Feb 13 2026. Currency figures normalised to Apyx Medical Corp's reporting currency: US Dollar USD
37.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nantahala Capital Management LLCas of 31 Dec 2025 | 3.97m | 9.69% |
| Archon Capital Management LLCas of 31 Dec 2025 | 3.21m | 7.83% |
| Royce & Associates LPas of 31 Dec 2025 | 2.44m | 5.95% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.35m | 3.30% |
| AIGH Capital Management LLCas of 31 Dec 2025 | 1.10m | 2.69% |
| Silverberg Bernstein Capital Management LLCas of 31 Dec 2025 | 1.03m | 2.52% |
| Commonwealth Equity Services LLCas of 31 Dec 2025 | 663.54k | 1.62% |
| Horizon Kinetics Asset Management LLCas of 31 Dec 2025 | 615.00k | 1.50% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 500.63k | 1.22% |
| Taylor Frigon Capital Management LLCas of 31 Dec 2025 | 437.96k | 1.07% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
